Haohai Biotech announced that on July 21, the company bought back 73,000 H shares at a price of HK$16.64-16.88 per share. The total price paid was HK$1,225,397. The company passed the repurchase authorization resolution on May 29, 2026. The total number of shares that can be repurchased was 3,478,034 shares. As of July 21, 234,000 shares had been purchased, accounting for 0.6728% of the shares issued on the day the resolution was passed. Following this share repurchase, the issuance of new shares or the resale or transfer of treasury shares will be suspended until August 20, 2026.

Haohai Biotech announced that on July 21, the company bought back 73,000 H shares at a price of HK$16.64-16.88 per share. The total price paid was HK$1,225,397. The company passed the repurchase authorization resolution on May 29, 2026. The total number of shares that can be repurchased was 3,478,034 shares. As of July 21, 234,000 shares had been purchased, accounting for 0.6728% of the shares issued on the day the resolution was passed. Following this share repurchase, the issuance of new shares or the resale or transfer of treasury shares will be suspended until August 20, 2026.